The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Making injectable and rectal artesunate available to vulnerable populations to address severe malaria (--> reduction in deaths of young children with severe malaria from 8% to < 0.5%)
Supporting development of a key easy-to-administer and long-protective antimalarial - dihydroartemisinin-piperaquine (Euroartesim).
Supporting malaria elimination in Papua New Guinea.
21,000 (population living in Lihir) 5,000 cases of malaria in 2015
2011 - ongoing
Treatment